Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses (2013)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1111/bcpt.12001
- Subjects: RECEPTORES ADRENÉRGICOS; PROTEÍNAS RECOMBINANTES; METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2013
- Source:
- Título: Basic and Clinical Pharmacology and Toxicology
- ISSN: 1742-7835
- Volume/Número/Paginação/Ano: v. 112, n. 2, p. 103-109, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERRAZ, Karina C. et al. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses. Basic and Clinical Pharmacology and Toxicology, v. 112, n. 2, p. 103-109, 2013Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12001. Acesso em: 13 fev. 2026. -
APA
Ferraz, K. C., Sousa-Santos, O., Neto-Neves, E. M., Rizzi, E., Muniz, J. J., Gerlach, R. F., & Tanus-Santos, J. E. (2013). Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses. Basic and Clinical Pharmacology and Toxicology, 112( 2), 103-109. doi:10.1111/bcpt.12001 -
NLM
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses [Internet]. Basic and Clinical Pharmacology and Toxicology. 2013 ; 112( 2): 103-109.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1111/bcpt.12001 -
Vancouver
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses [Internet]. Basic and Clinical Pharmacology and Toxicology. 2013 ; 112( 2): 103-109.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1111/bcpt.12001 - Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
Informações sobre o DOI: 10.1111/bcpt.12001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
